Clinical Trial Update: Study of Nivolumab for Advanced Cancers in India [Phase 4]

View source ↗

Summary

Phase 4 trial update for nivolumab in advanced cancers conducted in India, with completed status and results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Renal Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-Small Cell Lung Cancer (NSCLC), Non-Small-Cell Lung Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2020-12-04